Abstract
The effect of a high potency antacid and food on the bioavailability of famotidine was studied in 17 healthy volunteers in an open randomized three-way cross-over trial. After an overnight fast, famotidine was administered to each subject as follows: 40 mg famotidine orally alone; 40 mg orally with antacid; and 40 mg orally with a standard breakfast. Coadministration of the antacid caused a small but significant reduction in the maximum plasma concentration (Cmax) of famotidine from 81.1 +/- 54.2 to 60.8 +/- 21.6 ng ml-1 (P less than 0.05) and a small decrease in the area under plasma concentration-time curve [AUC] from 443.3 +/- 249.2 to 355.0 +/- 125.1 ng ml-1 h (P greater than 0.05). However, there was only a minimal effect of food on these parameters; the Cmax and [AUC] were 81.6 +/- 29.6 ng ml-1 and 434.8 +/- 145.9 ng ml-1 h, respectively.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gugler R., Brand M., Somogyi A. Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol. 1981;20(3):225–228. doi: 10.1007/BF00544602. [DOI] [PubMed] [Google Scholar]
- Kwan K. C., Till A. E. Novel method for bioavailability assessment. J Pharm Sci. 1973 Sep;62(9):1494–1497. doi: 10.1002/jps.2600620923. [DOI] [PubMed] [Google Scholar]
- Lin J. H., Los L. E., Ulm E. H., Duggan D. E. Urinary excretion kinetics of famotidine in rats. Drug Metab Dispos. 1987 Mar-Apr;15(2):212–216. [PubMed] [Google Scholar]
- Mihaly G. W., Marino A. T., Webster L. K., Jones D. B., Louis W. J., Smallwood R. A. High dose of antacid (Mylanta II) reduces bioavailability of ranitidine. Br Med J (Clin Res Ed) 1982 Oct 9;285(6347):998–999. doi: 10.1136/bmj.285.6347.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pendleton R. G., Torchiana M. L., Chung C., Cook P., Wiese S., Clineschmidt B. V. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist. Arch Int Pharmacodyn Ther. 1983 Nov;266(1):4–16. [PubMed] [Google Scholar]
- Vincek W. C., Constanzer M. L., Hessey G. A., 2nd, Bayne W. F. Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine. J Chromatogr. 1985 Mar 22;338(2):438–443. doi: 10.1016/0378-4347(85)80118-3. [DOI] [PubMed] [Google Scholar]
